Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19 ) and T helper epitopes of tetanus toxoid

Author: Keitel W.A.   Kester K.E.   Atmar R.L.   White A.C.   Bond N.H.   Holland C.A.   Krzych U.   Palmer D.R.   Egan A.   Diggs C.   Ballou W.R.   Hall B.F.   Kaslow D.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.18, Iss.5, 1999-10, pp. : 531-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content